RxDoctor Payments Data

Kristen Herring, MD

Family Medicine · Sumter, SCNPI 1437721578

Payments from drug & device makers

$1,776in general payments, 2019–2025

Across 83 payments — averaging $21.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$225
  • AbbVie$215
  • Novo Nordisk$204
  • AstraZeneca$185
  • Integra Lifesciences Corporation$175
  • Amgen$152
  • plus $620 from 15 others

What the payments were for

  • Food & beverage$1,776100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,776 in reported general payments places this provider in the 70th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$8,340
Medicare patients
64
Services billed
286

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide22$35,201
FarxigaDapagliflozin Propanediol22$19,608
EliquisApixaban19$18,356
XareltoRivaroxaban19$15,565
JardianceEmpagliflozin11$13,463
Amiodarone Hcl13$841
Rosuvastatin Calcium36$610
Albuterol Sulfate HfaAlbuterol Sulfate21$578
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$528
Trazodone Hcl16$397
Metformin Hcl23$386
Fluticasone Propionate29$358
Atorvastatin Calcium49$325
Quetiapine Fumarate16$298
Levothyroxine Sodium30$283

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$204$35,20122 claims
AstraZenecaFarxiga$185$19,60822 claims
PfizerEliquis$55$18,35619 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Sumter

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →